/ Not yet recruitingPhase 3IIT A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IIIb Clinical Trial Evaluating the Efficacy and Safety of RB0026 Injection in Chinese Children Aged 1-2 Years
100 Clinical Results associated with Ruiyang (Shandong) Biopharmaceutical Co., Ltd.
0 Patents (Medical) associated with Ruiyang (Shandong) Biopharmaceutical Co., Ltd.
100 Deals associated with Ruiyang (Shandong) Biopharmaceutical Co., Ltd.
100 Translational Medicine associated with Ruiyang (Shandong) Biopharmaceutical Co., Ltd.